The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 07, 2023
Filed:
Jul. 16, 2020
Applicant:
Wake Forest University Health Sciences, Winston-Salem, NC (US);
Inventors:
Anthony Atala, Winston-Salem, NC (US);
Gayoung Jeong, Winston-Salem, NC (US);
James J. Yoo, Winston-Salem, NC (US);
Sang Jin Lee, Winston-Salem, NC (US);
Young-Joon Seol, Winston-Salem, NC (US);
Assignee:
Wake Forest University Health Sciences, Winston-Salem, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/10 (2006.01); A61L 27/60 (2006.01); B33Y 80/00 (2015.01); B33Y 70/00 (2020.01); C08L 5/08 (2006.01); A61L 27/20 (2006.01); C08L 89/06 (2006.01); C12N 5/071 (2010.01); B29C 64/106 (2017.01); B33Y 10/00 (2015.01); A61L 27/18 (2006.01); A61L 27/38 (2006.01); A61L 27/52 (2006.01); G01N 33/50 (2006.01); B29K 75/00 (2006.01); B29K 105/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/60 (2013.01); A61F 2/10 (2013.01); A61L 27/18 (2013.01); A61L 27/20 (2013.01); A61L 27/3804 (2013.01); A61L 27/3813 (2013.01); A61L 27/3839 (2013.01); A61L 27/3891 (2013.01); A61L 27/52 (2013.01); B29C 64/106 (2017.08); B33Y 10/00 (2014.12); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); C08L 5/08 (2013.01); C08L 89/06 (2013.01); C12N 5/0698 (2013.01); G01N 33/502 (2013.01); G01N 33/5044 (2013.01); A61F 2210/0076 (2013.01); A61F 2240/001 (2013.01); A61L 2300/64 (2013.01); A61L 2430/34 (2013.01); B29K 2075/00 (2013.01); B29K 2105/0061 (2013.01); C12N 2502/091 (2013.01); C12N 2502/092 (2013.01); C12N 2502/094 (2013.01); C12N 2502/1305 (2013.01); C12N 2502/1323 (2013.01); C12N 2533/30 (2013.01); C12N 2533/54 (2013.01); C12N 2533/80 (2013.01);
Abstract
Provided are live, artificial, skin substitute products and methods of making and using the same, such as for wound treatment and compound testing, including compound testing for efficacy, toxicity, penetration, irritation and/or metabolism testing of drug candidates or compositions such as cosmetics.